glp-1 patch news 2025 📣 Health Update: A New Oral Option for Weight Management The FDA has approved the first oral medication for weight loss, expanding options beyond injections. ⚠️ Important reminder GLP-1 medications NuraPatch Reviews 2026: GLP-1 Patch

After adjusting for baseline risk factors, GLP-1 users had significantly lower recurrence rates than those using SGLT2 inhibitors or DPP-4 inhibitors

In particular, tell your provider if you have a past history of: Type 1 or type 2 diabetes Thyroid cancer Pancreatitis Kidney disease Diabetic retinopathy Tell your provider if you are pregnant, planning to become pregnant, or breastfeeding

Sadek MA, Kandil EA, El Sayed NS, Sayed HM, Rabie MA

Vital signs, particularly heart rate and blood pressure, are checked regularly, as GLP-1 agonists can slightly increase resting heart rate while beneficially lowering blood pressure

6X1A: Zhang X, Belousoff MJ, Zhao P, Kooistra AJ, Truong TT, Ang SY, Underwood CR, Egebjerg T, enel P, Stewart GD, Liang YL, Glukhova A, Venugopal H, Christopoulos A, Furness SGB, Miller LJ, Reedtz-Runge S, Langmead CJ, Gloriam DE, Danev R, Sexton PM, Wootten D

In practical terms, the therapeutic objective is not to mimic unopposed glucagon excess